TB-402 is a human IgG4 anticoagulant monoclonal antibody that partially inhibits Factor VIII. It exhibits long-lasting antithrombotic effects and can be studied for the prevention of venous thromboembolism (VTE) following total knee replacement (TKR) surgery.
Target-Kategorie:
Factor VIII
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
